Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Diet and Growth Hormone for Gut Adaptation in Short Bowel Syndrome
NCT00067860Phase 2Completed
- Sponsor
- Emory University
- Start
- Oct 1996
- Primary completion
- Dec 2006
- Modality
- Hormone, rProtein (Recombinant Protein), Biologic
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in short bowel syndrome (SBS) comparing Somatropin + Diet with Placebo + Diet (2 arms). Primary endpoint: Ability to wean patients from parenteral feeding at 6 months. Started Oct 1996; status: completed.
02
Drugs
somatropin
03
Conditions
short bowel syndrome (SBS)
Beyond the preview
Go deeper on NCT00067860.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00067860.